NDC17478-080-50: CAPREOMYCIN SULFATE.
The CAPREOMYCIN SULFATE is a the manufacturer industrial component. Key specifications include physical_form: FREEZE-DRIED POWDER, administration: INTRAVENOUS AND INTRAMUSCULAR, special_features: STORE AT ROOM TEMP OF 15 TO 30 C PRIOR TO RECONSTITUTION, features_provided: STERILE, primary_container_type: VIAL, protective_storage_feature: CONTROLLED ROOM TEMPERATURE. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-654-7966, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | FREEZE-DRIED POWDER |
| administration | INTRAVENOUS AND INTRAMUSCULAR |
| special_features | STORE AT ROOM TEMP OF 15 TO 30 C PRIOR TO RECONSTITUTION |
| features_provided | STERILE |
| primary_container_type | VIAL |
| protective_storage_feature | CONTROLLED ROOM TEMPERATURE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 10.0 MILLILITERS AFTER RECONSTITUTION |
| active_medicament_medicinal_strength | 1.0 GRAMS CAPREOMYCIN EQUIVALENT G |
| part_name_assigned_by_controlling_agency | CAPASTAT SULFATE - CAPREOMYCIN INJECTION, POWDER, FOR SOLUTION |
| NSN | 6505-01-654-7966 |
| ADMINISTRATION | INTRAVENOUS AND INTRAMUSCULAR |
| PRIMARY CONTAINER CONTENT QUANTITY | 10.0 MILLILITERS AFTER RECONSTITUTION |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | VIAL |
| PHYSICAL FORM | FREEZE-DRIED POWDER |
| SPECIAL FEATURES | STORE AT ROOM TEMP OF 15 TO 30 C PRIOR TO RECONSTITUTION |
| PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CAPASTAT SULFATE - CAPREOMYCIN INJECTION, POWDER, FOR SOLUTION |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.0 GRAMS CAPREOMYCIN EQUIVALENT G |